July 10, 2022

The cardiac presentation of transthyretin amyloidosis, otherwise known as transthyretin amyloid cardiomyopathy (ATTR-CM), can be life-threatening. Without proper support and treatment, ATTR-CM can cause heart failure (HF). Given the severe nature of the disease, patients with ATTR HF may experience higher costs of care than those with non-ATTR HF. This study, published in ESC Heart...

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a life-threatening heart condition historically considered a rare disease. Left untreated, ATTR-CM can lead to heart failure and other heart complications. Several mutations in the TTR gene are associated with the development of the disease. The V122I mutation is the most common variant in the United States, and around 4% of...